Propylene Glycol

Propylene Glycol

SCHEMBL20138436

CC(=O)OCC(CO)OC(C)=O.CC(O)CO

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Propylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 6/20 0.53
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropyl Alcohol SCHEMBL11286605 0.94 PRKCA (0.54) PRKCATDP1
Triacetin SCHEMBL890839 0.94 PRKCA (0.46) PRKCATDP1
SCHEMBL7758874 0.92 PRKCA (0.59) PRKCATDP1
SCHEMBL77521 0.92 PRKCA (0.59) PRKCATDP1
SCHEMBL7759898 0.92 PRKCA (0.59) PRKCATDP1
Triacetin SCHEMBL22160048 0.90 PRKCA (0.57) PRKCATDP1
Triacetin SCHEMBL15094105 0.89 PRKCA (0.43) PRKCATDP1
Glycerin SCHEMBL4461415 0.89 PRKCA (0.53) PRKCATDP1
SCHEMBL17707870 0.89 PRKCA (0.53) PRKCATDP1
Acetic Acid SCHEMBL8675242 0.88 PRKCA (0.56) PRKCATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12023402-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2024-07-02 US disclosed
EP-3534869-B1 ORAL CARE COMPOSITIONS COLGATE PALMOLIVE CO (US) 2023-09-06 EP disclosed
CN-110150279-B Preparation method for instant and rapid generation of peroxyacetic acid disinfectant 南通思锐生物科技有限公司 2023-08-25 CN disclosed
EP-3532021-B1 ANHYDROUS ORAL CARE COMPOSITION COLGATE PALMOLIVE CO (US) 2023-06-07 EP disclosed
CN-115105421-A Oral care compositions 高露洁-棕榄公司 2022-09-27 CN disclosed
CN-109982682-B Oral care compositions 高露洁-棕榄公司 2022-07-01 CN disclosed
US-20220142880-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2022-05-12 US disclosed
US-11090241-B2 Oral care compositions COLGATE-PALMOLIVE COMPANY (US) 2021-08-17 US disclosed
US-11090243-B2 Oral care composition COLGATE-PALMOLIVE COMPANY (US) 2021-08-17 US disclosed
US-10716742-B2 Oral care composition COLGATE-PALMOLIVE COMPANY (US) 2020-07-21 US disclosed
EP-3534869-A1 ORAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2019-09-11 EP disclosed
EP-3532021-A1 Oral Care Composition Colgate-Palmolive Company (US) 2019-09-04 EP disclosed
WO-2018118506-A1 ORAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
WO-2018118496-A1 ORAL CARE COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
WO-2018118498-A1 ORAL CARE COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 2018-06-28 WO disclosed
US-20180168969-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
US-20180168972-A1 Oral Care Composition COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
US-20180168993-A1 Oral Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2018-06-21 US disclosed
WO-2018093357-A1 Oral Care Composition COLGATE-PALMOLIVE COMPANY (US) 2018-05-24 WO disclosed
US-20180133130-A1 Oral Care Composition COLGATE-PALMOLIVE COMPANY (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12023402-B2 Oral care compositions VKORC1L1, PRDX1, VKORC1 PRKCA 3842/4885TDP1 2259/4885
US-20180133130-A1 Oral Care Composition PRDX1, PRDX2, PRDX4 PRKCA 4008/4885TDP1 1670/4885
US-20180168993-A1 Oral Care Compositions VKORC1L1, PRDX1, VKORC1 PRKCA 3842/4885TDP1 2259/4885
US-20220142880-A1 Oral Care Compositions VKORC1L1, PRDX1, VKORC1 PRKCA 3842/4885TDP1 2259/4885
US-11090243-B2 Oral care composition NONO, COG7, DSG1 PRKCA 4026/4885TDP1 2268/4885
US-20180168969-A1 Oral Care Compositions NONO, DSG1, SCD5 PRKCA 3772/4885TDP1 2669/4885
US-10716742-B2 Oral care composition PRDX1, PRDX2, PRDX4 PRKCA 4008/4885TDP1 1670/4885
US-11090241-B2 Oral care compositions NONO, DSG1, SCD5 PRKCA 3772/4885TDP1 2669/4885
US-20180168972-A1 Oral Care Composition NONO, COG7, DSG1 PRKCA 4026/4885TDP1 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.